The Truth About Chemical Abortion and Our Work to Stop It
At the Center for Client Safety, we exist for moments like this.
A groundbreaking new study released by the Ethics and Public Policy Center (EPPC) on April 28 confirms what we’ve been uncovering all along: Chemical abortion is far more dangerous than the abortion industry admits. Countless women and preborn children are suffering the consequences.
Chemical abortion now accounts for the majority of abortions in the United States, but the process is dangerously unregulated. Abortion pills can be ordered online with no medical oversight, no physical exam, and no legal safeguards, often from anonymous vendors overseas. Women are left to navigate this traumatic process alone, in their homes, without the support or protection they deserve.
Even in states with strong pro-life laws, these pills are being distributed in the shadows. There’s no way to determine gestational age, detect life-threatening conditions like ectopic pregnancy, or provide emergency care when something goes wrong. The risks are growing, and the Center for Client Safety must act.
Our work combats the chemical abortion industry and includes:
Investigating pill vendors, prescribers, and facilities operating outside the law
Documenting violations and pressing for action from regulators and medical boards
Shutting down dangerous providers that put women’s lives at risk
But that’s not all.
In partnership with Americans United for Life and the Ethics and Public Policy Center, the Center for Client Safety has taken decisive action to demand accountability from the federal government.
Last week, we joined more than 100 pro-life leaders to send a letter to Health and Human Services Secretary Robert F. Kennedy Jr. and FDA Commissioner Marty Makary, M.D., urging them to restore protections for women prescribed the abortion drug, mifepristone. The letter calls for a reversal of the dangerous Obama- and Biden-era policies that removed basic safeguards for abortion pills and their distribution.
Secretary Kennedy announced at a Senate hearing on May 14 that he has directed FDA Commissioner Makary to review the effects of abortion drugs.
The EPPC study is a wake-up call. It found:
Emergency room visits after chemical abortions rose over 500% between 2002 and 2015
By 2015, 35% of all abortion-related ER visits were due to complications from abortion pills
Two-thirds of women who visited emergency rooms for chemical abortion complications were misclassified as having miscarriages. Abortion providers coach women to lie to emergency room staff about what is causing their symptoms, leading to dangerous underreporting and mismanagement
The risk of emergency surgery is four times higher after a chemical abortion than a surgical one
This isn’t healthcare. It’s exploitation. And it proves why the Center for Client Safety’s mission is more urgent than ever.
We don’t just expose problems. We stop them.
With chemical abortions now making up well over half of all abortions in America, the need for real enforcement has never been greater. The abortion industry will not police itself. That’s why we’re here, and why we need you.
With your partnership, the Center for Client Safety will:
Expose the truth about abortion pills and their risks
Hold providers and manufacturers accountable for the harm they cause
Demand oversight in an industry that has operated unchecked for far too long
Together, we can build a future where women are protected, their children are welcomed, and the abortion industry is held accountable for the harm, and death, it causes.
You may donate here to help us stop the chemical abortion industry.
Thank you for standing with us!
